EGF Receptor-Targeting Cancer Therapy Using CD47-Engineered Cell-Derived Nanoplatforms

Moon Jung Choi,1 Kang Chan Choi,1 Do Hyun Lee,1 Hwa Yeon Jeong,1 Seong Jae Kang,1 Min Woo Kim,1 In Ho Jeong,1 Young Myoung You,1 Jin Suk Lee,2 Yeon Kyung Lee,1 Chan Su Im,1 Yong Serk Park1 1Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea; 2Department of Anato...

Descripció completa

Dades bibliogràfiques

Autors principals:	Choi MJ, Choi KC, Lee DH, Jeong HY, Kang SJ, Kim MW, Jeong IH, You YM, Lee JS, Lee YK, Im CS, Park YS
Format:	Artigo
Idioma:	Inglês
Publicat:	Dove Medical Press 2022-07-01
Col·lecció:	Nanotechnology, Science and Applications
Matèries:	cell-derived nanoparticles immune surveillance cd47 doxorubicin tumor targeting cancer therapy
Accés en línia:	https://www.dovepress.com/egf-receptor-targeting-cancer-therapy-using-cd47-engineered-cell-deriv-peer-reviewed-fulltext-article-NSA
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!